(Q34003547)

English

Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

cutaneous leishmaniasis

1 reference

based on heuristic

inferred from title

mucocutaneous leishmaniasis

1 reference

based on heuristic

inferred from title

1

object named as

T Aebischer

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

M Wolfram

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

S I Patzer

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

T Ilg

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

M Wiese

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

P Overath

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 March 2000

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Infection and Immunity

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

68

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1328-1336

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Recurrent cutaneous leishmaniasis: a role for persistent parasites?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Leishmania vaccines: old and new.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Antigen presentation by macrophages harboring intravesicular pathogens.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

A mitogen-activated protein (MAP) kinase homologue of Leishmania mexicana is essential for parasite survival in the infected host.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Gene cloning and cellular localization of a membrane-bound acid phosphatase of Leishmania mexicana.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Leishmaniasis: Immunological and clinical aspects and vaccines in Venezuela

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Saponins as vaccine adjuvants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Vaccines against leishmaniasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Structurally distinct genes for the surface protease of Leishmania mexicana are developmentally regulated

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Recombinant interleukin 12 cures mice infected with Leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells specific for amastigote cysteine proteinases requires intracellular killing of the parasites.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Expression cloning of a protective Leishmania antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

The regulation of immunity to Leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Monophosphoryl lipid A as an adjuvant. Past experiences and new directions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Development of a safe live Leishmania vaccine line by gene replacement.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Membrane glycoprotein M-2 protects against Leishmania amazonensis infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Influence of Lsh, H-2, and an H-11-linked gene on visceralization and metastasis associated with Leishmania mexicana infection in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

The promastigote surface protease (gp63) of Leishmania is expressed but differentially processed and localized in the amastigote stage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Experiences with vaccines against cutaneous leishmaniasis: of men and mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Immunoprotective Leishmania major synthetic T cell epitopes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

Membrane proteins and enzymes of Leishmania

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

5 July 2018

A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

29 October 2018

Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

29 October 2018

Expression of lipophosphoglycan, high-molecular weight phosphoglycan and glycoprotein 63 in promastigotes and amastigotes of Leishmania mexicana

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

29 October 2018

Genetic vaccination against leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

29 October 2018

Distribution of parasite cysteine proteinases in lesions of mice infected with Leishmania mexicana amastigotes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

29 October 2018

Protection against Leishmania major infection in genetically susceptible BALB/c mice by gp63 delivered orally in attenuated Salmonella typhimurium (AroA- AroD-)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=97286

29 October 2018

A radioattenuated Leishmania major vaccine markedly increases the resistance of CBA mice to subsequent infection with Leishmania mexicana mexicana

1 reference

https://pubmed.ncbi.nlm.nih.gov/10678945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccine development against cutaneous leishmaniasis. Subcutaneous administration of radioattenuated parasites protects CBA mice against virulent Leishmania major challenge

1 reference

https://pubmed.ncbi.nlm.nih.gov/10678945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10678945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/10678945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I: Skin-test reactivity, T-cell proliferation and interferon-gamma production

1 reference

https://pubmed.ncbi.nlm.nih.gov/10678945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10678945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous injection of irradiated Leishmania major into susceptible BALB/c mice: immunization or protective tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/10678945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/10678945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Whole-killed gp120-depleted HIV-1 antigen in a murine model for prophylactic vaccination

1 reference

https://pubmed.ncbi.nlm.nih.gov/10678945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/10678945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10678945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterologous protection in murine cutaneous leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10678945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant vaccine delivery systems and encoded vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/10678945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

QS-21: a water-soluble triterpene glycoside adjuvant

1 reference

https://pubmed.ncbi.nlm.nih.gov/10678945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Purification and characterization of a membrane-bound acid phosphatase of Leishmania mexicana

1 reference

https://pubmed.ncbi.nlm.nih.gov/10678945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meetings on vaccine studies towards the control of leishmaniasis. UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR) February 13-22 and April 4-5, 1995

1 reference

https://pubmed.ncbi.nlm.nih.gov/10678945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells by a model parasite antigen secreted into the parasitophorous vacuole or expressed on the amastigote surface

1 reference

https://pubmed.ncbi.nlm.nih.gov/10678945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The lysosomal gp63-related protein in Leishmania mexicana amastigotes is a soluble metalloproteinase with an acidic pH optimum

1 reference

https://pubmed.ncbi.nlm.nih.gov/10678945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major

1 reference

https://pubmed.ncbi.nlm.nih.gov/10678945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/IAI.68.3.1328-1336.2000

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34003547&oldid=1953614672"